Remegen Co., Ltd.

This study is testing two different drug combinations for people with advanced stomach cancer that has spread. Researchers want to see if adding newer targeted drugs to standard treatments helps control the cancer better. The trial will involve 201 adults who haven't had previous…

This study is testing if a drug called telitacicept, given as a weekly injection, can help slow down kidney damage in people with IgA nephropathy, a serious kidney disease. It involves 318 adults whose disease is progressing despite standard medication. The main goal is to see if…

This early-stage trial is testing a new drug called RC148, given alone or with other treatments, for people with advanced non-small cell lung cancer that has spread. The main goals are to see if the drug is safe and if it helps shrink or control tumors. The study will involve abo…